IL33 and graft versus host disease: IL-12–independent promotion of GVHD by IL-33 was further verified using il12rb2–/– donor T cells, which again suggested no role for IL-12 in IL-33–augmented GVHD lethality (Figure 1D) or clinical scores (Figure 1E).